Femasys appoints Dov Elefant as CFO effective Feb 28, 2022

FEMASYS INC

Dov Elefant, former CFO of Cellectar Biosciences, named CFO of Femasys.
Annual salary of $400,000; target bonus 40% of base salary.
Inducement option for 100,000 shares, vesting over four years.
Effective February 28, 2022, succeeding prior CFO arrangement.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dov Elefant

Chief Financial Officer

FEMY · FEMASYS INC

Effective: 2022-02-28
Filed: February 24, 2022, 6:59 PM ET

On February 24, 2022, Femasys Inc. (the “ Company ”) announced the hiring and appointment of Dov Elefant as its Chief Financial Officer, effective February 28, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dov Elefant was appointed as Chief Financial Officer at FEMASYS INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On February 24, 2022, Femasys Inc. (the “ Company ”) announced the hiring and appointment of Dov Elefant as its Chief Financial Officer, effective February 28, 2022.

View on SEC.gov

FEMASYS INC filing history →

Source: SEC EDGAR

accession 0001140361-22-006505

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.